Molgramostim Completed Phase 3 Trials for Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00880243Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)